Literature DB >> 17128685

Clinically diagnosed diabetic neuropathy: frequency, types and severity.

Solomon O Ugoya1, Godwins O Echejoh, Tokunbo A Ugoya, Emmanuel I Agaba, Fabian H Puepet, Adesola Ogunniyi.   

Abstract

OBJECTIVE: Studies of frequency of occurrence of diabetic neuropathy are few, and available studies were limited to the southern part of Nigeria. The objectives of the study were to determine the frequency of occurrence and grades of diabetes peripheral neuropathy using clinical measures. PATIENTS AND METHODS: Consecutive patients with diabetes mellitus attending the Jos University Teaching Hospital were recruited as the study population, including 120 diabetics and 60 age-matched, nondiabetic controls. A standard proforma based on the Michigan Neuropathy Screening Instrument (MNSI) was employed to screen for diabetic neuropathy.
RESULTS: The frequency of occurrence of diabetic peripheral neuropathy was 75%. For the specific types of peripheral neuropathy, sensorimotor neuropathy was the commonest (40.4%, chi(2)=29.1; p<0.001). There was no significant difference, with severity of peripheral neuropathy among diabetics, when compared by gender. (Chi square=3.03, P value=0.081).
CONCLUSION: The frequency of occurrence of peripheral neuropathy among diabetics in Jos University Teaching Hospital from this study is rather high.

Entities:  

Mesh:

Year:  2006        PMID: 17128685      PMCID: PMC2569794     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  10 in total

1.  Diabetes mellitus in Nigerians: a study of 832 patients.

Authors:  B O Osuntokun; F M Akinkugbe; T I Francis; S Reddy; O Osuntokun; G O Taylor
Journal:  West Afr Med J Niger Pract       Date:  1971-10

2.  [Prevalence and clinical aspects of cardiovascular vegetative neuropathy in a diabetic population].

Authors:  M Fernández-Castañer; G Mendola; I Levy; R Gomis; D Figuerola
Journal:  Med Clin (Barc)       Date:  1985-02-16       Impact factor: 1.725

3.  Casual blood glucose levels and prevalence of undiscovered diabetes mellitus in Lagos Metropolis Nigerians.

Authors:  A E Ohwovoriole; J A Kuti; S I Kabiawu
Journal:  Diabetes Res Clin Pract       Date:  1988-01-07       Impact factor: 5.602

4.  [Factors affecting the incidence and severity of polyneuropathy in type I diabetes mellitus].

Authors:  H Vondrová; V Bartos; J Skibová
Journal:  Cas Lek Cesk       Date:  1990-08-10

5.  High prevalence and severity of cardiac autonomic neuropathy in Vietnamese diabetic patients.

Authors:  N N'Guyen Thi; J Paries; J R Attali; P Valensi
Journal:  Diabet Med       Date:  2005-08       Impact factor: 4.359

6.  Divergent development of autonomic and peripheral somatic neuropathies in NIDDM.

Authors:  J P Töyry; J V Partanen; L K Niskanen; E A Länsimies; M I Uusitupa
Journal:  Diabetologia       Date:  1997-08       Impact factor: 10.122

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors:  M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

9.  A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.

Authors:  E L Feldman; M J Stevens; P K Thomas; M B Brown; N Canal; D A Greene
Journal:  Diabetes Care       Date:  1994-11       Impact factor: 19.112

10.  Diabetes mellitus in Saudi Arabia: The clinical pattern and complications in 1,000 patients.

Authors:  O O Famuyiwa; R A Sulimani; M A Laajam; S J Al-Jasser; M O Mekki
Journal:  Ann Saudi Med       Date:  1992-03       Impact factor: 1.526

  10 in total
  7 in total

1.  Prevalence, severity and factors associated with peripheral neuropathy among newly diagnosed diabetic patients attending Mulago hospital: a cross-sectional study.

Authors:  Twaha Kisozi; Edris Mutebi; Musubire Kisekka; Samden Lhatoo; Martha Sajatovic; Mark Kaddumukasa; Fredrick Nelson Nakwagala; Elly Katabira
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

2.  Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.

Authors:  Michael Olamoyegun; Waheed Ibraheem; Sandra Iwuala; Morenike Audu; Babatope Kolawole
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

3.  Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose.

Authors:  Anthonia Okeoghene Ogbera; Emmanuel Ezeobi; Chioma Unachukwu; Olajumoke Oshinaike
Journal:  Indian J Endocrinol Metab       Date:  2014-11

4.  Peripheral Sensory Neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia.

Authors:  Gashaw Jember; Yayehirad Alemu Melsew; Berihu Fisseha; Kedir Sany; Asmare Yitayeh Gelaw; Balamurugan Janakiraman
Journal:  J Diabetes Metab Disord       Date:  2017-04-04

5.  Neuropathy-specific alterations in a Mexican population of diabetic patients.

Authors:  Angélica Carbajal-Ramírez; Rebeca García-Macedo; Carlos Manlio Díaz-García; Carmen Sanchez-Soto; Araceli Méndez Padrón; Jorge Escobedo de la Peña; Miguel Cruz; Marcia Hiriart
Journal:  BMC Neurol       Date:  2017-08-25       Impact factor: 2.474

6.  Influence of gender on the distribution of type 2 diabetic complications at the obafemi awolowo teaching hospital, Ile-Ife, Nigeria.

Authors:  Adenike Enikuomehin; Babatope A Kolawole; Olubukunmi D Soyoye; Joseph O Adebayo; Rosemary T Ikem
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

7.  Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Yeshamble Work; Yared Asmare Aynalem
Journal:  BMC Endocr Disord       Date:  2020-04-15       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.